The hormone replacement therapy market is predicted to expand globally by 7.1% annually to reach US$ 12 billion in 2032.Based on geography, the global market for hormone replacement therapy is split into seven major regions: North America, South America, Eastern and Western Europe, Asia Pacific, Japan, Middle East, and Africa. The market for hormone replacement therapy is bigger in North America. The United States is the largest market in North America due to the rising use of Hormone Replacement Therapy among patients 35 years of age and above. Compound drugs, or medications in various dosage forms and strengths, are readily available, and this is one of the main factors driving this highly popular treatment market’s revenue growth. Additional significant market-driving factors Growing levels of disposable income and early ageing are contributing factors to revenue growth.In the upcoming years, the Asia region is anticipated to grow at a faster rate due to rising demand.
This region is becoming more aware of Hormone Replacement Therapy. Hormone Replacement Therapy is expected to grow at a faster rate in Asia, particularly in India, China, and Japan. Hormone Replacement Therapy is any type of hormone therapy in which the patient receives hormones as part of medical treatment, either to supplement a lack of naturally occurring hormones or to substitute other hormones for naturally occurring hormones.Menopause is the period in most women’s lives when their menstrual periods cease permanently and they are no longer able to bear children. Menopause typically occurs between the ages of 45 and 55. A decrease in hormone production by the ovaries is defined by medical professionals. Menopause usually occurs around the age of 40 in women who have had their uterus removed but still have ovaries.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-3871
Hormone Replacement Therapy Market: Drivers and Restraints
The prime drivers of hormone replacement therapy are increased demand from regenerative medicines such as anti-aging and reproductive-cycle boosting therapy such as menopausal hormone replacement. Rising demand in other therapeutic areas such as Growth Hormone Therapy and Thyroid Hormone Therapy due to comparatively safe profile, efficiency, and cost effectiveness of these drugs is expected to positively impact market growth.
Moreover, new formulations such as transdermal drugs, gels and creams that offer benefits such as ease of drug administration and impact at location are expected to increase the growth of hormone replacement therapy market during the forecast period. Advantages associated with the hormone replacement therapy such as reduction in risk incidence of osteoporosis, cardiovascular disease, and reduction of vasomotor symptoms are also expected to boost the growth of hormone replacement therapy market in the coming years.
Hormone Replacement Therapy has side effects such as fluid retention, headache, indigestion, and depression. These are anticipated to hamper the popularity of the therapeutic area. Furthermore, UK-based NICE notes that hormone replacement therapy could be associated with breast cancer risk if the drugs oestrogen and progesterone are taken in combination. Prolonged consumption of HRT drugs could also lead to increased risk of blood clots. Studies have estimated that for every 1,000 women taking HRT tablets for 7.5 years, less than two will develop a blood clot. These restraints seem quite negligible when compared with the benefits of HRT.
Hormone Replacement Therapy Market: Key Players
Some of the key market players in Global Hormone Replacement Therapy market are Bayer AG, Pfizer, Merck & co., BioSante Pharmaceuticals and Amgen, QuatRx Pharmaceuticals, Noven Pharmaceuticals.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Pipeline Assessment
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Unlock exclusive insights with our expert analysts:
https://www.futuremarketinsights.com/ask-question/rep-gb-3871
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil and Rest of Latin America)
- Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
- Eastern Europe (Poland, Russia and Rest of Eastern Europe)
- Asia Pacific without Japan (China, India, ASEAN, Australia & New Zealand, Rest of Asia Pacific without Japan)
- Japan
- Middle East and Africa (GCC, S. Africa, and Rest of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Based on Therapy Type,
- Estrogen Replacement Therapy
- Growth Hormone Replacement
- Dopamine Agonist
- Somatostatin Analogues
- Thyroid Hormone Replacement
- Tablets
- Capsules
- Injections
Based on Application
- Cancer
- Menopause
- Hypopituitarism
- Hypothyroidism
- Others
Based on Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies and Drugstores
- Compounding Pharmacies
- E-commerce
- Others
Unlock Tailored Insights: Customize Your Report for Maximum Impact :
https://www.futuremarketinsights.com/customization-available/rep-gb-3871
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
